Tim Bourgaize Murray: Hot Products Prove 'To Be Early Is to Be On Time'
From smart beta to liquid alternatives, Tim Bourgaize Murray explores the benefits of early adoption of new investment strategies and the need to think creatively about the technology required to get there.

Years ago I had a high school teacher, as many of us probably have, who would constantly rail on us, always reminding that “to be on time is to be late; to be early is to be on time.”
Why this was necessary, I don’t know—high school students are always prompt and on their best behavior, right? I’m sure I was. I’m less sure whether I’ve retained that sage wisdom and practice in my adult life as much as I should, but I can still hear those words rattling around in my head.
And rightly so. The adage could easily apply to more complicated matters of business as well. We regularly hear about the economic concept of “first-mover advantage” in financial services, and in financial technology, especially: Show up to market before the competition and reap the benefits.
But, somewhat to my surprise, I’ve often heard in the past three years that the opposite usually ends up being the technology strategy for firms: slow everything down wherever you can, even to a crawl if you need to.
Take regulation for example: why invest significant time and resources into something that always seems to change seven or eight times before it becomes law? Waiting makes a ton of sense in this case, and it seems like every conference we go to includes at least one C-level exec expressing (or, more accurately, loathing) this same sentiment coming from the business side, too.
Not every first-mover story is a success and when there is no easy, off-the-shelf option to start with, getting the technology right for a new product can be tricky. That’s especially true when you’re crossing over to a new investor segment like Larch Lane did, or swimming against the tide with what you’re selling, like Tobam was at first.
As Colin Powell famously said, once you break it, you own it and you fix it. And things usually get worse when the breaking is done in haste.
Early Risers
But sometimes, being early to the show pays huge dividends. This month’s buy-side coverage featured two terrific boutique examples of how and why. First let’s touch on liquid alternatives. Larch Lane Advisors, a private investor, partnered with Rothschild on a new ’40 Act mutual fund offering last year, just before the buy side became awash with investor demand for hedge fund risk in retail packaging. The company—with a long history and impeccable credentials, but still relatively small—knew building the necessary monitoring and reporting functions for a ’40 Act fund would be a challenge, so it partnered with Imagine Software to make that happen.
Second, we have equity smart beta and Paris-based Tobam, featured in this month’s profile of Yves Choueifaty.
As the CEO put it bluntly to me, being “anti-benchmark” before 2008 would have gotten you laughed out of a room. Still, he and his team were able to navigate choppy waters as they decoupled from Lehman Brothers, and today we see new indexes and other products from some of the largest buy-side firms on the Street all loudly trumpeting the smart beta gospel.
Tobam has grown from $2.5 billion to more than $9 billion under management in a couple of years as a result, but Choueifaty was candid about the keystone role Tobam’s internally-built portfolio management system, called Pilot, has played in convincing investors—early on and still today—that their product makes sense. Without that foresight, the firm would still be catching up with everyone else, and battling the scale that a BlackRock can leverage without a head start is almost certainly a losing proposition.
The Other Half
Of course, not every first-mover story is a success and when there is no easy, off-the-shelf option to start with, getting the technology right for a new product can be tricky. That’s especially true when you’re crossing over to a new investor segment like Larch Lane did, or swimming against the tide with what you’re selling, like Tobam was at first.
Many false starts have probably resulted, and I’m sure that this has led institutions both big and small to regularly brandish some product development projects to a kind of purgatory—if not a quick death once the money runs out.
That’s especially sad when you see a few new investment ideas like liquid alts and smart beta blossoming. With so many of investors’ needs still unmet by market offerings, who knows what else could be out there?
Perhaps being early is only half the battle; the other half is showing up with a solid plan.
Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.
To access these options, along with all other subscription benefits, please contact info@waterstechnology.com or view our subscription options here: https://subscriptions.waterstechnology.com/subscribe
You are currently unable to print this content. Please contact info@waterstechnology.com to find out more.
You are currently unable to copy this content. Please contact info@waterstechnology.com to find out more.
Copyright Infopro Digital Limited. All rights reserved.
As outlined in our terms and conditions, https://www.infopro-digital.com/terms-and-conditions/subscriptions/ (point 2.4), printing is limited to a single copy.
If you would like to purchase additional rights please email info@waterstechnology.com
Copyright Infopro Digital Limited. All rights reserved.
You may share this content using our article tools. As outlined in our terms and conditions, https://www.infopro-digital.com/terms-and-conditions/subscriptions/ (clause 2.4), an Authorised User may only make one copy of the materials for their own personal use. You must also comply with the restrictions in clause 2.5.
If you would like to purchase additional rights please email info@waterstechnology.com
More on Emerging Technologies
BlueMatrix acquires FactSet’s RMS Partners platform
This is the third acquisition BlueMatrix has made this year.
Waters Wavelength Ep. 331: Cresting Wave’s Bill Murphy
Bill Murphy, Blackstone’s former CTO, joins to discuss that much-discussed MIT study on AI projects failing and factors executives should consider as the technology continues to evolves.
FactSet adds MarketAxess CP+ data, LSEG files dismissal, BNY’s new AI lab, and more
The Waters Cooler: Synthetic data for LLM training, Dora confusion, GenAI’s ‘blind spots,’ and our 9/11 remembrance in this week’s news roundup.
Chief investment officers persist with GenAI tools despite ‘blind spots’
Trading heads from JP Morgan, UBS, and M&G Investments explained why their firms were bullish on GenAI, even as “replicability and reproducibility” challenges persist.
Wall Street hesitates on synthetic data as AI push gathers steam
Deutsche Bank and JP Morgan have differing opinions on the use of synthetic data to train LLMs.
A Q&A with H2O’s tech chief on reducing GenAI noise
Timothée Consigny says the key to GenAI experimentation rests in leveraging the expertise of portfolio managers “to curate smaller and more relevant datasets.”
Etrading wins UK bond tape, R3 debuts new lab, TNS buys Radianz, and more
The Waters Cooler: The Swiss release an LLM, overnight trading strays further from reach, and the private markets frenzy continues in this week’s news roundup.
AI fails for many reasons but succeeds for few
Firms hoping to achieve ROI on their AI efforts must focus on data, partnerships, and scale—but a fundamental roadblock remains.